The Bombay Burmah Trading Corporation (501425) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
13 Aug, 2026Executive summary
Unaudited standalone and consolidated financial results for the quarter ended 30 June 2026 were approved by the Board on 13 August 2026.
Independent auditors issued unqualified review reports for both standalone and consolidated results, confirming compliance with regulatory and accounting standards.
Financial highlights
Consolidated revenue from operations for Q1 FY27 was ₹5,088.69 crore, up from ₹4,817.99 crore in the previous quarter and ₹4,711.91 crore in Q1 FY26.
Consolidated profit after tax for Q1 FY27 was ₹582.67 crore, compared to ₹780.80 crore in the previous quarter and ₹497.66 crore in Q1 FY26.
Standalone revenue from operations for Q1 FY27 was ₹67.54 crore, with profit after tax at ₹7.86 crore.
Exceptional gain of ₹14.87 crore in Q1 FY27 from sale of Tea Plantation assets.
Outlook and guidance
The Group continues to monitor regulatory developments, including the implementation of new Labour Codes and ongoing legal proceedings related to an associate company.
Latest events from The Bombay Burmah Trading Corporation
- Net profit and revenue rose sharply, led by asset sales and food-bakery segment strength.501425
Q4 25/26 - Strong Q3 results, interim dividend declared, and MD re-appointed for five years.501425
Q3 25/26 - Q2 FY26 consolidated net profit reached ₹566 crore on revenue of ₹5,024 crore, driven by food-bakery.501425
Q2 25/26 - Strong Q1 profit and revenue growth, with major segment and management changes.501425
Q1 24/25 - H1 FY25 profit surged on robust food-bakery growth; new director appointed, dividend paid.501425
Q2 24/25 - Strong Q3 results, robust dividend, and stable financials despite regulatory risks.501425
Q3 24/25 - Strong FY25 profit growth, segment gains, and a qualified audit due to associate data gap.501425
Q4 24/25 - Revenue and profit rose, driven by food-bakery, with gains from asset sales and ongoing restructuring.501425
Q1 25/26